ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Recurrence
B-Cell Chronic Lymphocytic Leukemia
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Phoenix, AZ, USA:

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Scottsdale, Arizona, United States and 68 other locations

at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cem...

Active, not recruiting
Lymphoma, Non-Hodgkin's
Multiple Myeloma
Drug: Dexamethasone Oral
Drug: cemsidomide

Phase 1

C4 Therapeutics

Phoenix, Arizona, United States and 12 other locations

CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...

Active, not recruiting
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Genetic: CB-010
Drug: Cyclophosphamide

Phase 1

Caribou Biosciences

Scottsdale, Arizona, United States and 37 other locations

a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma...

Enrolling
Relapsed/Refractory Non-Hodgkin Lymphoma
Drug: Rituximab
Drug: Epcoritamab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Phoenix, Arizona, United States and 75 other locations

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling
T-cell Lymphoma
Cutaneous T-cell Lymphoma
Drug: Fenretinide

Phase 1

SciTech Development, Inc.

Scottsdale, Arizona, United States and 9 other locations

monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least tw...

Enrolling
Large B-Cell Lymphoma (LBCL)
B-cell Non-Hodgkin Lymphoma
Drug: Surovatamig

Phase 2

AstraZeneca
AstraZeneca

Phoenix, Arizona, United States and 92 other locations

receptor (CAR) T-cell therapy in patients with aggressive B-cell non-Hodgkin lymphoma that has come back after a period of...

Enrolling
Refractory ALK-Positive Large B-Cell Lymphoma
Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Procedure: Biospecimen Collection
Drug: Golcadomide

Phase 2

Mayo Clinic
Mayo Clinic

Scottsdale, Arizona, United States and 6 other locations

CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma...

Enrolling
Lymphoma, B-Cell
Diffuse Large B Cell Lymphoma Refractory
Biological: axicabtagene ciloleucel
Biological: lisocabtagene maraleucel

Phase 3

Lyell Immunopharma

Scottsdale, Arizona, United States and 43 other locations

A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas....

Enrolling
Hodgkin Lymphoma
Lymphoma
Drug: BiCNU
Drug: VI-0609

Phase 2

Vivus

Goodyear, Arizona, United States and 3 other locations

safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Mosunetuzumab (Cohorts A-C)
Drug: Mosunetuzumab (Cohorts D-E)

Phase 2

Genentech
Genentech

Phoenix, Arizona, United States and 40 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems